Autocrine expression of both endostatin and green fluorescent protein provides a synergistic antitumor effect in a murine neuroblastoma model

Cancer Gene Therapy

Volumn 8, Issue 7, 2001, Pages 537-545

  Davidoff, Andrew M ^a   Leary, Margaret A ^b   Ng, Catherine Y C ^a   Spurbeck, William W ^a   Frare, Pascale ^b   Vanhove, Marc ^b   Nienhuis, Arthur W ^b   Vanin, Elio F ^b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Antiangiogenesis; Endostatin; Gene therapy; Green fluorescent protein; Immunotherapy

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOCRINE EFFECT; CANCER IMMUNOTHERAPY; CANCER MODEL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENE THERAPY; IMMUNOMODULATION; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL DIVISION; CELL MOVEMENT; CELL SEPARATION; CELLS, CULTURED; CLONING, MOLECULAR; COLLAGEN; COMBINED MODALITY THERAPY; ENDOSTATINS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOTHERAPY; LUMINESCENT PROTEINS; MICE; MICE, SCID; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PLASMIDS; PROTEIN BIOSYNTHESIS; RECOMBINANT PROTEINS; RETROVIRIDAE; T-LYMPHOCYTES; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

ANIMALIA; MURINAE;

EID: 0034904063     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700346     Document Type: Article

References (34)

1. The role of angiogenesis in tumor growth
2. Mechanisms and therapeutic implications of angiogenesis
3. Tumor-associated angiogenesis: Mechanisms, clinical implications, and therapeutic strategies
4. Inhibition of angiogenesis
5. Anticancer strategies involving the vasculature: Vascular targeting and the inhibition of angiogenesis
6. Current approaches to targeting cancer using antiangiogenesis therapies
7. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
8. Endostatin induces endothelial cell apoptosis
9. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
10. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors
11. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
12. Angiostatin induces and sustains dormancy of human primary tumors in mice
13. Immunotherapy of a murine tumor with interleukin-2
14. Tumor immunotherapy: Cytokines and antigen presentation
15. Immunotherapy. Neuroblastoma as a model
16. Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity, immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors
17. Cancer vaccines
18. Immune response to green fluorescent protein: Implications for gene therapy
19. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow
20. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system
21. Identification of three N-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts
22. Adenovirus-mediated expression of therapeutic plasma levels of human factor IX in mice
23. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis
24. + progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors
25. Cellular carboxypeptidases
26. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene
27. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein
28. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement
29. Characterization of the murine T-cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
30. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
31. Mouse endostatin inhibits the formation of lung and liver metastases
32. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
33. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
34. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice